Philippine Ambassador to the Republic of India Ramon Bagatsing Jr. stated in an on-air interview that India is willing to export the controversial drug to the country for Covid19 treatment.
Bagatsing talked about how the antiparasitic veterinary drug has been used in India since last year as part of their additive treatment for mild cases of Covid19.
The envoy also urged the Food and Drug Administration (FDA) to authorize ivermectin in the country as both a treatment and prevention medication, or prophylaxis.
While ivermectin is only available in the Philippines in the form of topical creams for head lice and skin ailments, India on the other hand, locally manufactures pills of the drug for costing around P2.
Surging Covid19 infections in recent weeks led to the rising controversy surrounding the use of ivermectin as medication for Covid19.
Although some doctors have pushed for its use, the FDA and World Health Organization (WHO) have maintained that without concrete evidence to back the claims of effectiveness, it is not advisable to prescribe the drug.
The clamor has led to local clinical trials for the drug to be conducted, led by the Department of Science and Technology (DOST).
Despite the current lack of evidence however, three unnamed private hospitals in the country have been granted a compassionate special permit (CSP) by the FDA for the use of ivermectin.
Some medical experts have labeled the move as a “political” one, rather than a medical decision.
All the while, the Covid19 pandemic has hit a dangerous new period in India as a more transmissible “double mutant” variant of the SARS-CoV-2 virus was recently discovered there, amid reports of government complacency.
India’s total recorded cases of Covid19 comes in at more than 17 million as of April 26.